Prestige and Profit: Hotel Property Event Confirms Eight Distinguished Panelists


The INSEAD Alumni Association of Switzerland welcomes members and special guests to an evening conference about investing in hotel property, featuring two panel discussions with leading industry insiders. The “Prestige and Profit: Global Hotel Property Investment Insights” conference will be held on Thursday, June 5, 2014 at Zunfthaus zur Zimmerleuten in Zürich.
The hotel and lodging sector is proving to be one in which prestige and profit are not necessarily mutually exclusive. There is an increasing level of private capital, equity and debt financing underway, driven by renewed investor confidence and pent-up demand. As a result, there has been a “remarkable increase” in M&A transaction activity as noted by Ernst & Young in its latest hospitality industry report.The two panel discussions, along with an interactive session with attendees, promise to engage with an interchange amongst champions of luxury assets and champions of return on investment.Event organizer, Francesco Noseda, Director of Financière Eos, a leading French investment firm dedicated to the lodging sector, and former Chairman Swiss International Hotels, will moderate the panels. Confirmed panelists include Benoît-Etienne Domenget, COO Accor Switzerland, Laurent Dusonchet, Managing Partner, Avangard Advsiory, Dr. Timo Grünert, CFO Oetker Collection, Antoine Hubert, Board Delegate, Aevis Holding SA, Peter Norman, Senior VP Acquisitions & Development, Hyatt International, Jean-Gabriel Pérès, CEO Movenpick Hotels, and Bruno H. Schöpfer, Managing Director, The Bürgenstock Selection, Katara Hospitality Switzerland AG.

Come and learn more about the latest investment trends and value drivers, as well as emerging geographic hotspots and innovative product niches that are driving returns.

[important]Tickets available now on[/important]

Where: Zunfthaus zur Zimmerleuten Limmatquai 40, 8001 Zürich

When: Thursday, June 5, 2014


  • 6:00 Cocktail Reception
  • 6:30 Welcome from INSEAD Alumni Association Switzerland
  • 6:45 Panel 1: Is Trophy Asset  Investing Rational?
  • 7:15 Panel 2: Can New Geographic And Product Segments Yield Superior Growth And Return Potential? 
  • 7:45 Dialogue Session with Panelists
  • 8:00 Apéro Riche

Price:  SFr 70 for INSEAD NAA members / SFr 100 for other INSEAD Alumni and Guests

After Work Aboard Le Bateau Hosted by INSEAD Geneva

genevabannerdrinks INSEAD Geneva Spring After-work Aboard

Le Bateau Paddle-Steamer

bateaugenfThursday May 22, 2014

Dear All,

Spring is finally here, and we have the pleasure of inviting you to come aboard Switzerland’s oldest paddle ship for this year’s INSEAD Spring after-work event in Geneva. Join us on Le Bateau, moored at Quai Gustave-Ador.

Do feel free to bring your partner or a friend along. The more the merrier!

Date: Thursday May 22, 201418:30 to 21:00
Venue: Le Bateau (buvette du Bateau)
Quai Gustave-Ador1207 Genève
Confirmation: Please kindly confirm your attendance by e-mail to yves (dot) haldemann (at) bluewin.chby Tuesday, May 20, 2014.
Cost: Approx. 30 CHF/person, consumption to be paid directly at the bar.Tapas and “planchette” are available.

Best regards,

Yves Haldemann (MBA’94D)

INSEAD Alumni Association Switzerland – Geneva Chapter


Pharma Dealmaking Up 428%: What’s Driving It?

M&A activity in the pharmaceutical and medical industries is up by 428% in deal volume in the first quarter of the year, according to data provider mergermarket. What is driving the current spate of deals? How wise it? The answer to these questions, and other insights on M&A will be topics at “Build, Borrow, Buy”, an evening conference in Geneva coming up on Thursday May 15, 2014.


Pharma industry companies announced 62 deals valued at USD 40.5bn in Q1 2014, up by 427.8% over the same period last year (USD 7.7bn in deals), and almost double the previous quarter. Source: MergerMarket.

Pharmaceutical industry M&A is being described variously as a “boom” and “frenzy” in the press. The impact on the involved companyies’ growth and survival rate are topics that INSEAD Professor Laurence Capron is expected to explore in-depth in her presentation at the upcoming event.

She will also moderate a panel of high-profile life science industry executives, venture capital and corporate finance professionals, including Marvelle Sullivan, Head of Global M&A Novartis, Michèle Ollier, LifeSciences, Partner, Index Ventures, Jean-Pierre Rosat, CEO, Aleva NeuroTherapeutics, Alex Schmitz, VP Business Development, Biosensors International, Daniel Kubitza, Executive Director UBS, and Thimo Sommerfeld, Co-Founder and Managing Director, Abolon Group.

This event will also be a great opportunity to welcome the Wharton Alumni Club, Professor Capron having directed the INSEAD-Wharton alliance from 2007-2010. More details and tickets on